This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
The Zacks Analyst Blog Highlights: Banner, Amazon.com, BJ's, athenahealth and BioTelemetry
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Banner, Amazon.com, BJ's, athenahealth and BioTelemetry
Bull Run Set to Become the Longest in History: 5 Winners
by Tirthankar Chakraborty
The current bull market in U.S. stocks is about to become the longest on record, and optimistic analysts are predicting that it has miles to go before it rests.
Should First Trust Small Cap Growth AlphaDEX Fund (FYC) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for FYC
Top Ranked Momentum Stocks to Buy for August 7th
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, August 7th:
Options Traders Expect Huge Moves in BioTelemetry (BEAT) Stock
by Zacks Equity Research
BioTelemetry (BEAT) needs investors to pay close attention to the stock based on moves in the options market lately.
Zacks.com featured highlights include: BioTelemetry, Fair Isaac, Comerica and Blue Hills
by Zacks Equity Research
Zacks.com featured highlights include: BioTelemetry, Fair Isaac, Comerica and Blue Hills
4 Top Stocks to Buy on Blockbuster Earnings Growth
by Tirthankar Chakraborty
We shortlist four solid stocks that have striking earnings growth and positive estimate revisions.
Top Ranked Momentum Stocks to Buy for July 31st
by Zacks Equity Research
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, July 31st:
Elevate Credit (ELVT) and BioTelemetry (BEAT) Are Aggressive Growth Stocks
by Brian Bolan
A look at two stocks for your aggressive growth stock radar.
NovoCure (NVCR) Catches Eye: Stock Jumps 7.4%
by Zacks Equity Research
NovoCure (NVCR) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.
Biocept, Inc. (BIOC) Soars: Stock Adds 9.8% in Session
by Zacks Equity Research
Biocept (BIOC) was a big mover last session, as the company saw its shares rise more than 9% on Friday amid huge volumes.
Natera (NTRA) Catches Eye: Stock Jumps 6.3%
by Zacks Equity Research
Natera (NTRA) shares rose more than 6% in the last trading session, amid huge volumes.
BioTelemetry (BEAT) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
BioTelemetry (BEAT) sees strong Q4 results, courtesy of solid acquisitions and promising performance by the MCT platform.
BioTelemetry's (BEAT) Telcare Unit Collaborates With Onduo
by Zacks Equity Research
BioTelemetry (BEAT) progresses with deals to strengthen hold in the high-potential diabetes care market.
BioTelemetry Ties Up With Apple, Grows in Cardiac Monitoring
by Zacks Equity Research
BioTelemetry (BEAT) is consistently trying to improve its position in the cardiac monitoring and diagnostic services space.
BioTelemetry (BEAT) Q3 Earnings Miss, Revenues Meet Estimates
by Zacks Equity Research
A decline in gross and operating margin was a major drag for BioTelemetry (BEAT) in the third quarter.
BioTelemetry, Royal Gold, Microsoft and Amazon highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
BioTelemetry, Royal Gold, Microsoft and Amazon highlighted as Zacks Bull and Bear of the Day
Bull of the Day: BioTelemetry (BEAT)
by Kevin Cook
This small veteran in the "connected health" space doesn't need to beat Apple to win
PAREXEL's Acquisition by Pamplona Approved by Shareholders
by Zacks Equity Research
The long-awaited PAREXEL (PRXL) acquisition by Pamplona Capital Management finally receives shareholders' approval. Moreover, the company plans to go private post-acquisition.
Here's Why Mazor Robotics (MZOR) Stock Is Worth a Bet Now
by Zacks Equity Research
The market is upbeat about Mazor Robotics' (MZOR) recent CE Mark approval for Mazor X Surgical Assurance platform.
Here's Why You Should Invest in Orthofix International Now
by Zacks Equity Research
Orthofix (OFIX) rides high on strength in Biologics and Spine Fixation.
Zacks.com featured highlights include JA Solar Holdings, BioTelemetry, Arista Networks, Owens Corning and Aaron's
by Zacks Equity Research
Zacks.com featured highlights include JA Solar Holdings, BioTelemetry, Arista Networks, Owens Corning and Aaron's
Here's Why You Should Bet on BioTelemetry (BEAT) Stock Now
by Zacks Equity Research
BioTelemetry's (BEAT) consistent efforts in product innovation through research and development buoy optimism. Also, the recent acquisition instills confidence in investors.
5 Momentum Stocks Powered by Driehaus Strategy
by Zacks Equity Research
One of the most widely used investment approaches for those interested in momentum stocks is the Driehaus strategy
Can BioTelemetry (BEAT) Run Higher on Strong Earnings Estimate Revisions?
by Zacks Equity Research
BioTelemetry (BEAT) is seeing solid earnings estimate revisions, and the stock is showing decent short-term momentum as well.